Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings
Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia
La FDA aprobó un nuevo medicamento para tratar los sofocos moderados a graves causados por la menopausia
Fresh2 Reports Fiscal Year 2022 Annual Financial Results
America’s Best Wings: Everything You Need to Know
Beijing Express: Fabrice and Briac stop in the Gers to promote the fight against cancer
Exfoliation, hydration: honey, a nectar with many virtues for the skin
“He’s fine” … Michel Drucker released from hospital after having heart surgery
Vegetable crisps, a healthy alternative?
Eating broccoli against skin allergies
SUZHOU, China, May 16, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and...